BioStem Technologies (BSEM) vs Instil Bio (TIL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
BioStem Technologies (BSEM) has outperformed Instil Bio (TIL) over the past year, losing 50.5% versus a loss of 62.9%. Over five years, BSEM leads with a +70.7% price change compared with -98.1% for TIL. Instil Bio is the larger company by market cap ($46.3 million vs $45.4 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BSEM | TIL |
|---|---|---|
| Share price | $2.43 | $6.83 |
| Market cap | $45.37M | $46.32M |
| 1-day change | +1.67% | -0.29% |
| YTD return | -37.27% | -37.27% |
| 1-year return | -50.52% | -62.86% |
| 5-year return | +70.71% | -98.07% |
| P/E ratio (TTM) | 2.76 | — |
| Forward P/E | 8.38 | — |
| EPS (TTM) | $0.88 | $-4.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.40 | $21.98 |
| 52-week low | $2.25 | $5.67 |
| Distance from 52-week high | -71.07% | -68.93% |
| Average volume | 120.39K | 11.93K |
| Shares outstanding | 18.67M | 6.78M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BSEM has outperformed TIL by 12.3 percentage points over the past year.
BSEM vs TIL FAQ
Which is bigger, BioStem Technologies or Instil Bio?
Instil Bio (TIL) is larger, with a market capitalization of $46.32M compared with $45.37M for BioStem Technologies (BSEM).
Which stock has performed better over the past year, BSEM or TIL?
BSEM returned -50.52% over the past 12 months, compared with -62.86% for TIL (price return, excluding dividends). Past performance does not predict future results.
Are BioStem Technologies and Instil Bio in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.